Right patient.
Right time. Right line.
The BioFlo® Midline Catheter is the first – and only – midline catheter with Endexo® Technology, providing a catheter material more resistant to invitro thrombus accumulation, compared to commonly used catheters (based on platelet count).*
The BioFlo® Midline Catheter:
- Provides short-term access (<30 days) to the peripheral venous system
- Intended for select intravenous therapies and blood sampling
- 20 cm trimmable catheter
- Present throughout the catheter shaft (intraluminal, extraluminal, and cut surface)
BIOFLO® MIDLINES
94%
LESS THROMBUS ACCUMULATION
LESS THROMBUS ACCUMULATION
compared to competitors
(based on platelet count)*

* The reduction in thrombus accumulation (based on platelet count) is supported by acute invitro testing. Pre-clinical invitro evaluations do not necessarily predict clinical performance with respect to thrombus formation.